2,3-Dimethyl-5-(2-methylbutyl)pyrazine
Common Name: |
2,3-Dimethyl-5-(2-methylbutyl)pyrazine |
IUPAC Name: |
2,3-dimethyl-5-(2-methylbutyl)pyrazine |
Molecular Formula: |
C10H16N2 |
SMILES: |
CCC(C)CC1=CN=C(C(=N1)C)C |
Inchi: |
1S/C11H18N2/c1-5-8(2)6-11-7-12-9(3)10(4)13-11/h7-8H,5-6H2,1-4H3 |
Inchi Key: |
QJQUDEDFDDMKGC-UHFFFAOYSA-N |
Cas No: |
75492-01-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
164.25 |
Mass (g/mol) |
178.147 |
Molar Refractivity |
51.35 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
25.78 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
244.00 to 245.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.046 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
2.682 |
iLOGP |
2.41 |
XLOGP3 |
2.28 |
WLOGP |
2.44 |
MLOGP |
1.17 |
ESOL Log S |
-2.47 |
ESOL Solubility (mg/ml) |
0.561 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.46 |
Ali Solubility (mg/ml) |
0.57 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-4.02 |
Silicos-IT Solubility (mg/ml) |
0.02 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.68 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.687 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.801 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |